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Molecular and Functional Analysis of
Tumor-Suppressor Genes by Transfection
by Reinhold Schafer,* Jaya Iyer,* Elsbeth Iten,t Arto C.
Nirkko,t Johannes Balmer,* and Roman Klemenz*
The transformed and tumorigenic phenotype of H-ras transfected rat FE-8 cells can be suppressed by
cell fusion with normal rat embryo fibroblasts. Transfection into FE-8 cells ofDNA prepared from normal
human placenta followed by selective elimination of tumorigenic transfected cell clones resulted in the
isolation of phenotypically normal revertants. These cells exhibited a fibroblastlike, normal morphology;
were anchorage-dependent; and were unable to proliferate in medium with reduced serum concentrations.
Their tumorigenicity was also reduced. The suppressed phenotype has been transferred in a second trans-
fection cycle. Human repetitive DNA sequences were detected in secondary transfectant DNA. A putative
human suppressor gene, designated NTS-1, has been molecularly cloned. Reintroduction of cloned NTS-
1 sequences into FE-8 cells resulted in suppression of the neoplastic phenotype in spite of a high ras
expression.
Introduction
Genetic analysis of the neoplastic phenotype by so-
matic cell hybridization of tumor and normal cells has
revealed that tumorigenic cells have accumulated ge-
netic defects, resulting in the loss of gene activity es-
sential for normal growth control. Tumorigenicity and
transformed phenotypes are frequently abolished in tu-
mor x normal hybrids (suppression of maligancy) (1-
3). Several suppressor gene loci have been assigned to
specificchromosomes inthehumanandrodent genomes.
The suppressor genes active in tumor x normal somatic
cell hybrids may be identical to those genes whose func-
tional inactivation is associated with human malignan-
cies; however, their molecular nature is not yet known.
The function of tumor-suppressor genes, anti-onco-
genes, or recessive genes is fundamentally different
fromthatofcellular oncogenes inthatthey donot confer
transformed properties upon normal cells (1,4). Rather,
they appear to constrain the proliferation of trans-
formed cells. We wished to study the phenomenon of
tumor suppression in a cell system in which the neo-
plastic phenotype is triggered by a cellular oncogene
frequently detected in human tumors. We established
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a functional assay for the molecular identification of
DNA sequences associated with the induction of the
suppressed phenotype. A putative tumor-suppressor
gene, designated NTS-1, has been molecularly cloned.
Suppression of Neoplastic
Phenotype in H-ras Transformed Rat
FE-8 Cells by Cell Fusion
Immortalized, nontumorigenic rat 208 F cells (defi-
cient in hypoxanthine phosphoribosyltransferase activ-
ity, HPRT-) were cotransfected with an activated hu-
man H-ras gene (EJ-ras) and the pSVneo gene.
Transfectants were selected inmedium containingG418
(Geneticin). One G418-resistant clone, FE-8, was cho-
sen as the transformed parental cell line in subsequent
cell fusion experiments. This clone contains four to five
copies of the transfected ras gene and expresses high
levels of p21. The cells exhibit a transformed morphol-
ogy, form large colonies in semi-solid agar medium at
a high efficiency, proliferate in medium with reduced
serum concentrations, and initiate progressively en-
larging tumors in newborn rats or nude mice without a
detectable latency period.
HPRT-deficient, G418-resistant FE-8 cells were
fused with normal rat embryo fibroblasts (REF), and
somaticcellhybridswere selectedinmediumcontaining
G418 and hypoxanthine, aminopterine, and thymidine
(HAT additives). The hybrid clones resistant to HAT
and G418 wereisolated andanalyzed forras expression,
the expression oftransformed phenotypes invitro, and
fortumorigenicity. In spite ofahigh levelofras expres-SCHAFER ETAL.
sion, FE-8 x REF somatic cell hybrids were nontu-
morigenic in newborn rats and no longer proliferated in
semi-solid agarmedium (5). Tumorigenicity reappeared
in segregants with a reduced chromosome number de-
rivedfromthe suppressed hybrid clones. Similarresults
have beenobtainedinsomaticcellhybridsinvolvingras-
transformed Chinese hamster (CHEF) cells (6) or hu-
man EJ bladder carcinoma cells (7) and normal fibro-
blasts.
Suppression of Neoplastic
Phenotype in H-ras Transformed
FE-8 Cells by DNA Transfection
To identify and molecularly clone a suppressor gene
that abolishes the neoplastic phenotype in ras-trans-
formed cells, we have developed a functional assay
based on DNA transfection. We assumed that an intact
suppressor gene could be transfected into H-ras trans-
formed FE-8 cells and exert its transformation-sup-
pressing function even in the presence of the trans-
forminggene. Highmolecularweight DNAfromnormal
human placenta was cotransfected into FE-8 cells, to-
gether with the plasmid pY3 harboring a resistance
gene encoding the hygromycin B phosphotransferase.
Transfectants were selected in medium containing hy-
gromycin B (HmB). A population of more than 6000
HmB-resistant, FE-8 transfectant clones was gener-
ated, inwhichthehumandonorgenomewaspresumably
represented several times. The population of trans-
fected FE-8 cells was treated with the cardiac amino-
glycoside ouabain in a second selection step. This drug
has been shown to selectively kill ras-transformed cells
in K+-free medium, whereas nontransformed cells are
able to survive the treatment (8). Colonies that had
survived the ouabain selection were analyzed for the
retention ofatransforming ras gene, forthe expression
ofthe suppressed phenotype, and for the integration of
human repetitive Alu sequences. Some of the selected
transfectants appeared to be phenotypically unstable.
Primary transfectants F4 and F9 retaineda normal fi-
broblastlikemorphologyevenafterfurthermaintenance
in cell culture. These phenotypic revertants required
high serum concentrations forgrowth, formed smallcol-
onies in semi-solid agar medium at a low efficiency, and
theirtumorigenicityinnewbornratswasreduced. How-
ever, the two cell lines continued to express p21 athigh
levels.
The presence ofa transforming ras gene in clones F4
and F9 was assayed by NIH 3T3 transfection. DNA
prepared from F4 and F9 revertants was cotransfected
into NIH 3T3 cells. Transfected NIH 3T3 cells were
injected into nude mice. Tumors developed within afew
weeks. The EJ-ras gene was detected in all such tu-
mors. The partially suppressed phenotype was trans-
ferable in a second transfection cycle. DNA prepared
from F4 and F9 cells was used as the donor DNA to-
gether with the pY3 plasmid in the second transfection
cycle. Secondary transfected revertants were isolated
after the two-step selection protocol. In a parallel ex-
periment, F9 DNA was transfected without an added
resistancegene. Transfectantswere selectedinmedium
containing HmB, and the ouabain treatment was omit-
ted. This transfection experiment gave rise to a series
of secondary transfectants, which retained a normnal or
intermediate morphology, and showed suppression of
anchorage-independent growth and a reduced tumori-
genicity.
We then attempted to molecularly clone the trans-
fected human sequences from one ofthe revertant FE-
8 clones. Clone FS9-7 harbored a single exogenous 18
kb BamHI fragment, as detected by hybridization to a
human repetitive DNA probe. The same transfected
DNA fragment was detectable by a pY3 probe. We
concluded that the resistance gene used in the first
transfection cycle and the human DNA fragment re-
sponsible for the expression of the suppressed pheno-
typemusthavebeencloselylinkeduponintegrationinto
the genome of tumonrgenic FE-8 cells.
Molecular Cloning of the Candidate
Suppressor Gene NTS-1
A recombinant phage library was constructed by in-
serting BamHI-digested FS9-7 DNA into the BamHI-
site of the substitution phage vector EMBL 3. Six
hundred thousand recombinant phages were screened
for the presence of human repetitive DNA and for the
hygromycin B phosphotransferase gene. Three recom-
binantphages, designated X97-1, X97-2, andX97-3, were
identified that harbored an 18 kb BamHI DNA-insert
hybridizing to either probe. Recombinant phage DNAs
werethentransfected intoFE-8cells, andtransfectants
were selected in medium containing HmB. HmB-re-
sistant clones were isolated after transfection of X97-1
and X97-3 DNA (Table 1). All HmB-resistant transfec-
tants analyzed exhibited a low efficiency of cloning in
soft agar medium. Individual colonies were small (less
than 100 cells per colony) (Table 1). The tumorigenicity
ofthese transfectants was reduced. We concluded from
this experiment that the cloned 18 kb BamHI fragment
Table 1. Induction of the suppressed phenotype
in H-ras transformed rat FE-8 cells: a comparison of
transfection efficiencies.
Calculated no. of colonies
with suppressed phenotype/
,ug DNA/106 transfected cells Donor DNA
Human placenta 0.02a
X97-1 500b
X97-2 c
X97-3 500b
pY3 < 0.003
Mock transfection
(no DNA) < 0.001
aColonies identified after two-step selection protocol (see text).
bHmB-resistant colonies were directly analyzed for growth in soft
agar medium. Ouabain selection was omitted. eTransfection of X97-2 DNA did not give rise to HmB-resistant
colonies. Suppressive activity ofthis clone was not analyzed.
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contained afunctional human gene, capable ofsuppress-
ing the transformed phenotype of H-ras transformed
cells (9). The 18 kb BamHI fragment consists of DNA
sequences encoding the hygromycin B phosphotrans-
ferase gene under the control of Moloney LTR se-
quences, ahumanAlu element, andunique human DNA
sequences that are linkedtoratDNAsequences derived
from the recipient cell line.
Further transfection experiments using fragments
derived from the original phage isolate, subcloned in a
plasmid vector, have shown that a genomic DNA frag-
ment, on which aunique human DNAsequence islinked
to the resistance gene, is sufficient to confer the sup-
pressed phenotype on FE-8 cells. Various transcripts
related to NTS-1 have been detected in RNA of FE-8
transfectants. The sequence of the human genomic
DNAelement has been determined. Three openreading
frames coding for polypeptides consisting of42, 55, and
61 amino acids have been identified. These polypeptides
are not homologous to any known protein sequence in
the SWISSPROT data base. Experiments aimed at the
further characterization of the putative suppressor
gene, the isolation ofthe corresponding cDNA, analysis
of its chromosomal localization, and of its expression
pattern in normal and tumorigenic cells are in progress.
Suppression of Neoplastic
Phenotype in Cells Transformed by
Tyrosine Kinase Oncogenes
To determine whether the NTS-1 gene would coun-
teracttheexpressionoftheneoplasticphenotypeincells
transformedbyoncogenes otherthanras, weperformed
a series of cell fusion experiments. A revertant clone
F9 (HPRT-, HmB resistant) was fused with mouse
NIH 3T3 or208F ratcelllines (HPRT+, HmB sensitive)
containingthe v-src orv-fgroncogenes andwithamouse
NIH 3T3 cell line (HPRT+, HmB sensitive) trans-
formed by polyoma virus. Somatic cell hybrids were
selected in medium containing HmB, HAT additives,
and semi-solid agar. The ratio ofhybrid colonies prolif-
erating in monolayer cultures to that ofhybrids prolif-
erating in semi-solid agar medium was determined. In
control experiments, we generated somatic cell hybrids
between the same transformed cell lines and normal rat
208F-3 cells or with tumorigenic FE-8Y cells (HPRT-,
HmB resistant). Cell fusions involving the cell lines
transformed by tyrosine kinase oncogenes and both
208F-3 cells or F9revertants harboringtheNTS-1 gene
yielded hybrid populations that were anchorage-depen-
dent. In contrast to this, all hybrids involving Polyoma
virus transformed cells continued to express the trans-
formed phenotype. All hybrids between FE-8Y cells
and transformed NIH 3T3 or 208F cells were trans-
fonned (10). These results suggest that the suppressor
gene identified by transfection into H-ras transformed
cells is capable ofsuppressing the neoplastic phenotype
in cells transformed by tyrosine kinase oncogenes.
Conclusions
The transformed phenotype of H-ras transfected rat
FE-8 cells can be suppressed by transected of DNA
sequences derivedfromnormalhumancells. HumanAlu
sequences, detected in secondary transfected rever-
tants, were used to identify the DNA sequence (NTS-
1) associated with the expression of the suppressed
phenotype. All revertants continued to express the
transforming ras gene at high levels. Thus, the mech-
anism ofsuppression involves a process downstream of
the initial interaction of the ras gene product with its
target molecule(s). Understanding the mechanism of
partial reversion in this cell system will require the
characterization oftheNTS-1 suppressor gene product,
its subcellular localization, and expression pattern in
normal and transformed cells. NTS-1 probes will be
used to screen for changes in expression in suppressed
somatic cell hybrids and in tumorigenic segregants as
well as in human tumors.
Based on a similar functional assay, we have recently
identified another human DNA sequence that is asso-
ciated with the reversion ofthe transformed phenotype
in transfectants derived from a spontaneously trans-
formed Chinese hamster cell line (11; unpublished re-
sults). The candidate suppressor gene NTS-1 is not re-
lated to this sequence, nor is it related to the K-rev-1
gene (12), a suppressor gene identified by transfection
of a human foreskin cDNA library into K-ras trans-
formed NIH 3T3 cells. Thus, transfection into trans-
formed cells of normal genomic DNA or of cDNAs iso-
lated from normal cells has proved to be a useful
approach to identify and clone candidate suppressor
genes. These experiments, however, donot define arole
for such genes in the process of human tumorigenesis.
Rather, human tumors will have to be screened for ge-
netic defects in the corresponding genes in order to
search for a significant function in the initiation and
progressionofhumanneoplasia. Theavailabilityoffunc-
tional molecular clones provides a unique tool to study
suppressive effects in various cell systems and in cells
transformedbyoncogene products ofdifferentbiochem-
ical functions.
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